Clinicopathologic Characteristics and Clinical Outcome of Localized Liposarcoma: A Single-Center Experience over 25 Years and Evaluation of PD-L1 Expression

PURPOSE: For liposarcoma (LPS), clinical course and proper treatment strategies have not been well-established. Recently, immune-checkpoint inhibitors have shown potential efficacy in LPS. We aimed to describe the clinical course of LPS and evaluate the clinical impact of programmed death-ligand 1 (...

Descripción completa

Detalles Bibliográficos
Autores principales: Chae, Heejung, Kim, Jeong Eun, Kim, Wanlim, Lee, Jong-Seok, Song, Si Yeol, Lee, Min Hee, Chung, Hye Won, Cho, Kyung-Ja, Song, Joon Seon, Ahn, Jin-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016292/
https://www.ncbi.nlm.nih.gov/pubmed/34237209
http://dx.doi.org/10.4143/crt.2021.496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016292/
https://www.ncbi.nlm.nih.gov/pubmed/34237209
http://dx.doi.org/10.4143/crt.2021.496

Ejemplares similares